MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
532
Unique beneficiaries
—
Total services
804
Distinct HCPCS
9
Medicare payment
$48K
Peer benchmark
Total Medicare services vs. 170 Endocrinology providers in MD — below median (cohort median 1,214).
PRESCRIBING · PART D · 2024
Total Rx claims
2,587
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
41
Brand share
61.5%
Top prescribed drugs
Semaglutide237 claims
Empagliflozin161 claims
Atorvastatin Calcium156 claims
Metformin Hcl129 claims
Metformin Hcl124 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Kristi Silver's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 6 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | 60 | 317 |
| Univ Of Md Pathology Associates P A Clinical Laboratory · Baltimore, MD | 30 | 126 |
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 28 | 132 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 26 | 76 |
| Elizabeth Lamos Endocrinology · Baltimore, MD | 17 | 23 |
| Kashif Munir Endocrinology · Baltimore, MD | 15 | 25 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| MARYLAND GENERAL HOSPITAL INC | 203 | 836 |
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | 70 | 318 |
| Univ Of Md Pathology Associates P A Clinical Laboratory · Baltimore, MD | 31 | 163 |
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 23 | 138 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 17 | 45 |
| NPI 1679521017 | 11 | 90 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE